Advertisement

Varicella—Herpes Zoster Virus

  • Thomas H. Weller

Abstract

Varicella—zoster virus (Herpesvirus varicellae), commonly abbreviated to “V-Z virus” or “VZV,” is the etiologic agent of two diseases of man, varicella and herpes zoster. Varicella (chickenpox) is a ubiquitous, contagious, generalized exanthematous disease of seasonally epidemic propensities that follows primary exposure of a susceptible person, most often a child. Herpes zoster (shingles) is an endemic sporadic disease, most frequent in elderly people, characterized by the appearance of a unilateral, painful, vesicular eruption localized to the dermatome innervated by a specific dorsal root or extra-medullary cranial ganglion. In contrast to varicella, which follows primary exogenous contact with the causative virus, zoster reflects endogenous activation of a VZV infection that has survived in latent form following an attack of varicella. The two clinical entities are not as distinct as is customarily assumed. The patient with zoster frequently develops a disseminated varicelliform eruption; rarely, the person with varicella may exhibit a zosteriform concentration of lesions.

Keywords

Herpes Zoster Varicella Vaccine Oral Acyclovir Acute Viral Infection Susceptible Child 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Alkalay, A. L., Pomerance, J. J., and Rimain, D. L., Fetal varicella syndrome, J. Pediatr. 111: 320–323 (1987).PubMedCrossRefGoogle Scholar
  2. 2.
    Antonelli, M. A. S., Moreland, L. W., and Brick, J. E., Herpes zoster in patients with rheumatoid arthritis treated with weekly low-dose methotrexate, Am. J. Med. 90: 295–298 (1991).PubMedGoogle Scholar
  3. 3.
    Armstrong, R. W., Gurwith, M. J., Waddell, D., and Merigan, T. C., Cutaneous interferon production in patients with Hodgkin’s disease and other cancers infected with varicella or vaccina, N. Engl. J. Med. 283: 1182–1187 (1970).PubMedCrossRefGoogle Scholar
  4. 4.
    Armstrong, R. W., and Merigan, T. C., Varicella-zoster virus: Interferon production and comparative interferon sensitivity in human cell cultures, J. Gen. Viral. 12: 53–54 (1971).CrossRefGoogle Scholar
  5. 5.
    Arvin, A. M., Koropchak, C. M., and Wiiek, A. E., Immunologic evidence of reinfection with varicella-zoster virus, J. Infect. Dis. 148: 200–205 (1983).PubMedCrossRefGoogle Scholar
  6. 6.
    Arvin, A. M., Pollard, R. B., Rasmussen, L. E., and Merigan, T. C., Selective impairment of lymphocyte reactivity to varicella zoster virus antigen among untreated patients with lymphoma, J. Infect. Dis 137: 531–540 (1978).PubMedCrossRefGoogle Scholar
  7. 7.
    Arvin, A. M., Pollard, R. B., Rasmussen, L. E., and Merigan, T. C., Cellular and humoral immunity in the pathogenesis of recurrent herpes viral infections in patients with lymphoma, J. Clin. Invest. 65: 869–878 (1980).PubMedCrossRefGoogle Scholar
  8. 8.
    Asano, Y., Hiroishi, Y., Itakura, N., Hirose, S., Kajita, Y, Nagal, T., Yazaki, T., and Takahashi, M., Immunoglobulin subclass antibodies to varicella zoster virus, Pediatrics 80: 933–936 (1987).PubMedGoogle Scholar
  9. 9.
    Asano, Y., Itakura, N., Hiroshi, Y., Hirose, S., Nagai, T., Ozaki, T., Yazaki, T., Yamanishi, K., and Takahashi, M., Viremia is present in incubation period in nonimmunocompromised children with varicella, J. Pediatr. 106: 69–71 (1985).PubMedCrossRefGoogle Scholar
  10. 10.
    Asano, Y., Nagai, T., Miyata, T., Yazaki, T., Ito, S., Yamanishi, K., and Takahashi, M., Long-term protective immunity of recipients of the Oka-strain live varicella vaccine, Pediatrics 75: 667–671 (1985).PubMedGoogle Scholar
  11. 11.
    Baba, K., Yabuuchi, H., Okuni, H., and Takahashi, M., Studies with live varicella vaccine and inactivated skin test antigen; protective effect of vaccine and clinical application of the skin test, Pediatrics 61: 550–555 (1978).PubMedGoogle Scholar
  12. 12.
    Baba, K., Yabuuchi, H., Takahashi, M., and Ogra, P., Immunologic and epidemiologic aspects of varicella infection acquired during infancy and early childhood, J. Pediatr. 100: 881–885 (1982).PubMedCrossRefGoogle Scholar
  13. 13.
    Balfour, H. H., JR., Editorial. Acyclovir therapy for herpes zoster: Advantages and adverse effects, J.A.M.A. 255: 387–388 (1986).PubMedCrossRefGoogle Scholar
  14. 13a.
    Balfour, H. H., JR., Current management of varicella zoster infections, J. Med. Viral. Suppl. 1: 74–81 (1993).CrossRefGoogle Scholar
  15. 14.
    Barrett, M. J., Hurwitz, E. S., Schonberger, L. B., and Rogers, M. F., Changing epidemiology of Reye syndrome in the United States, Pediatrics 77: 598–602 (1986).PubMedGoogle Scholar
  16. 15.
    Berger, R., Florent, G., and Just, M., Decrease of the lymphoproliferative response to varicella-zoster antigen in the aged, Infect. Immun. 32: 24–27 (1981).PubMedGoogle Scholar
  17. 16.
    Berger, R., Luescher, D., and Just, M., Enhancement of varicella-zoster specific immune responses in the elderly by boosting with varicella vaccine, J. Infect. Dis. 149: 647 (1984).PubMedCrossRefGoogle Scholar
  18. 17.
    Biron, C. A., Byron, K. S., and Sullivan, J. L., Severe herpes-virus infections in an adolescent without natural killer cells, N. Engl. J. Med. 320: 1731–1735 (1989).PubMedCrossRefGoogle Scholar
  19. 18.
    Black, F. L., Hiebholzer, W. J., Pinheiro, F., Evans, A. S., Woodall, J. P., Obton, E. M., Emmons, J. E., West, B. S., Edsall, G., Downs, W. G., and Wallace, G. D., Evidence for persistence of infectious agents in isolated human populations, Am. J. Epidemiol. 100: 230–250 (1974).PubMedGoogle Scholar
  20. 19.
    Blakely, G. A., Lourie, B., Morton, W. G., Evans, H. H., and Kaufmann, A. F., A varicella-like disease in macaque monkeys, J. Infect. Dis. 127: 617–623 (1973).PubMedCrossRefGoogle Scholar
  21. 20.
    Blendon, R. J., The changing epidemiology of Reye’s syndrome in the United States; further evidence for a public health success, J.A.M.A. 260: 3178–3180 (1988).CrossRefGoogle Scholar
  22. 20a.
    Bodensteiner, J. B., Hills, M. R., and Riggs, J. E., Clinical features of vascular thrombosis following varicella, Am. J. Dis. Child. 146: 100–102 (1992).PubMedGoogle Scholar
  23. 21.
    Boggergoren, S., Bernstein, J. M., Gershon, A. A., and Ogra, P. L., Mucosal cell-mediated immunity to varicella-zoster virus: Role in protection against disease, J. Pediatr. 105: 195–199 (1984).CrossRefGoogle Scholar
  24. 22.
    Broussard, R. C., Payne, D. K., and George, R. B., Treatment with acyclovir of varicella pneumonia in pregnancy, Chest 99: 1045–1047 (1991).PubMedCrossRefGoogle Scholar
  25. 23.
    Brunell, P. A., Placental transfer of varicella-zoster antibody, Pediatrics 38: 1034–1038 (1966).PubMedGoogle Scholar
  26. 24.
    Brunell, P. A., Varicella-zoster infections in pregnancy, J.A.M.A. 199: 315–317 (1967).PubMedCrossRefGoogle Scholar
  27. 25.
    Brunell, P. A., Gershon, A. A., Uduman, S. A., and Steinberg, S., Varicella-zoster immunoglobulins during varicella, latency, and zoster, J. Infect. Dis. 132: 49–54 (1975).PubMedCrossRefGoogle Scholar
  28. 26.
    Brunell, P. A., Ross, A., Miller, L. H., and Kuo, B., Prevention of varicella by zoster immune globulin, N. Engl. J. Med. 280: 1191–1194 (1969).PubMedCrossRefGoogle Scholar
  29. 27.
    Buchbinder, S. P., Katz, M. H., Hessol, N. A., Liu, N. A., Liu, J. Y., O’Malley, P. M., Underwood, R., and Holmberg, S. D., Herpes zoster and human immunodeficiency virus infection, J. Infect. Dis. 166: 1154–1156 (1992).Google Scholar
  30. 28.
    Burke, B. L., Steele, R W., Beard, O. W., WooD, J. S., Cain, T. D., and Marmer, D. J., Immune responses to varicella-zoster in the aged, Arch. Int. Med. 142: 291–293 (1982).Google Scholar
  31. 29.
    Campbell-Benzie, A., Heath, R. B., Ridehalgh, M. K. S., and Cradockwatson, J. E., A comparison of indirect immunofluorescence and radioimmunoassay for detecting antibody to varicella-zoster virus, J. V irol. Methods 6: 135–140 (1983).Google Scholar
  32. 30.
    Centers For Disease Control, Zoster immune globulin, Morbid. Mortal. Week. Rep. 25: 211–212 (1976).Google Scholar
  33. 31.
    Centers For Disease Control, Varicella-zoster immune globulin distribution, 1981–1983. Recommendations of the Immunization Practices Committee on use of immune globulin for the prevention of chickenpox, Morbid. Mortal. Week. Rep. 33: 8190 (1984).Google Scholar
  34. 32.
    Centers For Disease Control, Annual summary, 1983. Reported morbidity and mortality in the United States, Morbid. Mortal. Week. Rep. 32 (54): 1–125 (1984).Google Scholar
  35. 33.
    Centers For Disease Control, Summary of notifiable diseases, United States, 1991, Morbid. Mortal. Week. Rep. 40 (53): 164 (1992).Google Scholar
  36. 34.
    Cheatham, W. J., Weller, T H, Dolan, T. F., and Dower, J. C., Varicella; report of two fatal cases with necropsy, virus isolation, and serologic studies, Am. J. Pathol. 32: 1015–1035 (1956).PubMedGoogle Scholar
  37. 35.
    Cohrs, R., Mahalingam, R., Dueland, A. N., Wolf, W., Wellish, M., and Gilden, D. H., Restricted transcription of varicella-zoster virus in latently infected human trigeminal and thoracic ganglia, J. Infect. Dis. 166 (Suppl. 1): S24–29 (1992).PubMedCrossRefGoogle Scholar
  38. 36.
    Colbunders, R., Mann, J. M., Francis, H., Bila, K., Izaley, L., Kakonde, N., Quinn, T. C., Curran, J. W., and Piot, P., Herpes zoster in African patients; a clinical predictor of human immunodeficiency virus infection, J. Infect. Dis. 157: 314–318 (1988).CrossRefGoogle Scholar
  39. 37.
    Collins, S. D., Wheeler, R. E., and Shannon, R. D., The Occurrence of Whooping Cough, Chickenpox, Mumps, Measles, and German Measles in 200,000 Surveyed Families in 28 Large Cities, Special Study Series, No. 1, Division of Public Health Methods, Nih, Usphs, Washington, DC, 1942.Google Scholar
  40. 38.
    Committee ON Infectious Diseases, American Academy OF Pediatrics, The use of oral acyclovir in otherwise healthy children with varicella, Pediatrics 91: 674–676 (1993).Google Scholar
  41. 39.
    Cradock-Watson, J. E., Ridehalgh, M. K. S., and Bourne, M. S., Specific immunoglobulin responses after varicella and herpes zoster, J. Hyg. (Comb.) 82: 319–336 (1979).CrossRefGoogle Scholar
  42. 40.
    Demmler, G. J., Steinberg, S. P., Blum, G., and Gershon, A. A., Rapid enzyme-linked immunosorbent assay for detecting antibody to varicella-zoster virus, J. Infect. Dis. 157: 211–212 (1988).PubMedCrossRefGoogle Scholar
  43. 41.
    Dlugosch, D., Eis-Hubinger, A. M., Kleim, J. P., Kaiser, R., Bierhoff, E., and Schneweis, K. E., Diagnosis of acute and latent varicella-zoster virus infections using the polymerase chain reaction, J. Med. Virol. 35: 136–141 (1991).Google Scholar
  44. 42.
    Dunkle, L. M., Arvin, A. M., Whitley, R. J., Rotbart, H. A., Feder, H. M., Feldman, S., Gershon, A. A., Levy, M. L., Hayden, G. E, Mcguirt, P. V., Harris, J., and Balfour, H. H., A controlled trial of acyclovir for chickenpox in normal children, N. Engl. J. Med. 325: 1539–1544 (1991).PubMedCrossRefGoogle Scholar
  45. 42a.
    Echevarria, J. M., Casas, 1., Tenorio, A., DE Ory, F., and Martinezmartin, P., Detection of varicella-zoster virus-specific Dna sequences in cerebrospinal fluid from patients with acute aseptic meningitis and no cutaneous lesions, J. Med. Virol. 43: 331–335 (1994).Google Scholar
  46. 43.
    Eckstein, R., Jehn, U., and Loy, A., Endemic chickenpox on a cancer ward, J. Infect. Dis. 149: 829–830 (1984).PubMedCrossRefGoogle Scholar
  47. 44.
    Edson, C. M., Hosler, B. A., Respess, R. A., Waters, D. J., and Thorleylawson, D. A., Cross reactivity between herpes simplex virus glycoprotein B and a 63,000 dalton varicella-zoster virus envelope glycoprotein, J. Virol. 56: 333–336 (1985).PubMedGoogle Scholar
  48. 44a.
    Enders, G., Miller, M., Cradock-Watson, J., Bolley, I., and Ridehalgh, M., Consequences of varicella and herpes zoster in pregnancy; prospective study of 1739 cases, Lancet 343: 1547–1550 (1994).CrossRefGoogle Scholar
  49. 45.
    Feder, H. M., Treatment of adult chickenpox with oral acyclovir, Arch. Intern. Med. 150: 2061–2065 (1990).PubMedCrossRefGoogle Scholar
  50. 46.
    Feldman, S., Chaudary, S., Ossi, M., and Epp, E. A., A viremic phase for herpes zoster in children with cancer, J. Pediatr. 91: 597–600 (1977).PubMedCrossRefGoogle Scholar
  51. 47.
    Feldman, S., Hughes, W. T., and Kim, H. Y., Herpes zoster in children with cancer, Am. J. Dis. Child. 126: 178–184 (1973).PubMedGoogle Scholar
  52. 48.
    Feldman, S., and Lorr, L., Varicella in children with cancer: Impact of antiviral therapy and prophylaxis, Pediatrics 80: 465–472 (1987).PubMedGoogle Scholar
  53. 49.
    Fleisher, G., Henry, W., Mcsorley, M., Arbeter, A., and Plotkin, S., Life threatening complications of varicella, Am. J. Dis. Child. 135: 896–899 (1981).PubMedGoogle Scholar
  54. 50.
    Forghani, B., Schmidt, N. J., and Dennis, J., Antibody assays for varicella-zoster virus: Comparison of enzyme immunoassay with neutralization, immune adherence hemagglutination and complement fixation, J. Clin. Microbiol. 8: 545–552 (1978).PubMedGoogle Scholar
  55. 51.
    Foung, S. K. H., Perkins, S., Koropchak, C., Fishwild, D. M., Wittek, A. E., Engleman, E. G., Grumet, E. C., and Arvin, A. M, Human monoclonal antibodies neutralizing varicella-zoster virus, J. Infect. Dis. 152: 280–285 (1985).PubMedCrossRefGoogle Scholar
  56. 52.
    Frey, H. M., Bialkin, G., and Gershon, A. A., Congenital varicella: Case report of a serologically proved long-term survivor, Pediatrics 59: 110–112 (1977).PubMedGoogle Scholar
  57. 53.
    Frey, H. M., Steinberg, S. P., and Gershon, A. A., Diagnosis of varicella-zoster infections, in: The Human Herpesviruses. An Interdisciplinary Perspective (A. J. Nahmias, W. R. Dowdle, And R. E Schinazi, Eds.), pp. 351–362, Elsevier, New York, 1981.Google Scholar
  58. 54.
    Friedman, M. G., Haikin, H., Leventonkriss, S., Joffe, R., Goldstein, V., and Sarov, I., Detection of antibodies to varicella zoster virus by radio-immunoassay and enzyme immunoassay techniques, Med. Microbiol. Immunol. 166: 177–186 (1978).PubMedCrossRefGoogle Scholar
  59. 55.
    Furuta, Y., Takasu, Y., Fukuda, S., Satomatsumura, K. C., Inuyama, Y., Hondo, R., and Nagashima, K., Detection of varicella-zoster Dna in human geniculate ganglia by polymerase chain reaction, J. Infect. Dis. 166: 1157–1159 (1992).PubMedCrossRefGoogle Scholar
  60. 56.
    Garland, J., Varicella following exposure to herpes zoster, N. Engl. J. Med. 228: 336–337 (1943).CrossRefGoogle Scholar
  61. 56a.
    Garnett, G. P., Cox, J. M., Bundy, D. A. P., Didier, J. M., and ST. Catherine, J., The age of infection with varicella-zoster virus in St. Lucia, West Indies, Epidemiol. Infect. 110: 361–372 (1993).PubMedCrossRefGoogle Scholar
  62. 57.
    Garnett, G. P., and Grenfell, B. T., The epidemiology of varicella-zoster virus infections: A mathematical model, Epidemiol. Infect. 108: 495–511 (1992).PubMedCrossRefGoogle Scholar
  63. 58.
    Garnett, G. P., and Grenfell, B. T., The epidemiology of varicella-zoster infections: The influence of varicella on the prevalence of zoster, Epidemiol. Infect. 108: 513–528 (1992).PubMedCrossRefGoogle Scholar
  64. 59.
    Gershon, A. A., Varicella vaccine; still at the cross roads, Pediatrics 90 (Suppl.): 144–148 (1992).PubMedGoogle Scholar
  65. 60.
    Gershon, A. A., Brunell, P. A., Doyle, E. E, and Clapps, A. A., Steroid therapy and varicella, J. Pediatr. 81: 1034 (1972).PubMedCrossRefGoogle Scholar
  66. 61.
    Gershon, A. A., Frey, H. M., Steinberg, S. P., Seeman, M. D., Bidwell, D., and Voller, A., Determination of immunity to varicella using an enzyme-linked-immunosorbent assay, Arch. Virol. 70: 169–172 (1981).PubMedCrossRefGoogle Scholar
  67. 62.
    Gershon, A. A., And Krugman, S., Seroepidemiologic survey of varicella: Value of specific fluorescent antibody test, Pediatrics 56: 1005–1008 (1976).Google Scholar
  68. 62a.
    Gershon, A. A., Larussa, P., and Steinberg, S., Detection of antibodies to varicella-zoster virus using a latex agglutination assay, Clin. Diagn. Virol. 2: 271–277 (1994).PubMedCrossRefGoogle Scholar
  69. 63.
    Gershon, A. A., Raker, R., Steinberg, S., Topfolstein, B., and Drusin, L. M., Antibody to varicella-zoster virus in parturient women and their offspring during the first year of life, Pediatrics 58: 692–696 (1976).PubMedGoogle Scholar
  70. 64.
    Gershon, A. A., and Steinberg, S. P., Cellular and humoral immune responses to varicella-zoster virus in immunocompromised patients during and after varicella-zoster infections, Infect. Immun. 25: 170–174 (1979).PubMedGoogle Scholar
  71. 65.
    Gershon, A., Steinberg, S., and Brunell, P. A., Zoster immune globulin: A further assessment, N. Engl. J. Med. 290: 243245 (1974).Google Scholar
  72. 66.
    Gershon, A. A., Steinberg, S. P, Gelb, L., and The National Institute OF Allergy And Infectious Diseases Collabora- 82. Tive Varicella Vaccine Study Group, Clinical reinfection with varicella-zoster virus, J. Infect. Dis. 149: 137–142 (1984).CrossRefGoogle Scholar
  73. 67.
    Gershon, A. A., Steinberg, S., and Smith, M., Cell-mediated 83. immunity to varicella-zoster virus demonstrated by viral inac- tivation with human leucocytes, Infect. Immun. 13: 1549–1553 (1976).PubMedGoogle Scholar
  74. 68.
    Gilchrest, B., and Baden, H. P., Photodistribution of viral exanthems, Pediatrics 54: 136–138 (1974).PubMedGoogle Scholar
  75. 68a.
    Gilden, D. H., Beinlich, B. R., Rubinstien, E. M., Stommel, E., Swenson, R., Rubinstein, D., and Mahalingam, R., Varicella-zoster myelitis, an expanding syndrome, Neurology 44: 1818–1823 (1994).PubMedCrossRefGoogle Scholar
  76. 69.
    Gilden, D. H., Vafai, A., Shtram, Y., Becker, Y., Devlin, M., and Wellish, M., Varicella-zoster virus Dna in human sensory ganglia, Nature 306: 478–480 (1983).PubMedCrossRefGoogle Scholar
  77. 70.
    Glynn, C., Crockford, G., Davaghan, D., Cardno, P., Price, D., and Miller, J, Epidemiology of shingles, J. R. Soc. Med. 83: 617–619 (1990).PubMedGoogle Scholar
  78. 70a.
    Gogos, C. A., Apostolidou, E., Bassaris, H. P., and Vagenakis, A. G., Three cases of varicella thrombophlebitis as a 88. complication of varicella zoster infection, Eur. J. Clin. Microbiol. Infect. Dis. 12: 43–45 (1993).PubMedCrossRefGoogle Scholar
  79. 71.
    Gold, E., Serologic and virus-isolation studies of patients with varicella or herpes-zoster infection, N. Engl. J. Med. 274: 181–185 (1966).PubMedCrossRefGoogle Scholar
  80. 72.
    Goldberg, R. D., and Sarov, I., Enzyme-linked immunosor- bent assay for detection of antibodies to varicella-zoster virus, Isr. J. Med. Sci. 16: 111–117 (1980).PubMedGoogle Scholar
  81. 73.
    Gordon, J. E., General considerations of modes of transmission, in: Preventive Medicine in World War II, Vol. IV, Communicable 91. Diseases, p. 27, Department of the Army, Washington, DC, 1958.Google Scholar
  82. 74.
    Gordon, J. E., Chickenpox: An epidemiological review, Am. J. 91a Med. Sci. 244: 362–389 (1962).Google Scholar
  83. 75.
    Gray, G. C., Palinkas, L. A., and Kelley, P. W., Increasing incidence of varicella hospitalizations in United States army and navy personnel; are today’s teenagers more susceptible? Should recruits be vaccinated? Pediatrics 86: 867–873 (1990).Google Scholar
  84. 76.
    Grose, C., Edwards, D. P, Friedrichs, W. E., Weigle, K. A., and McGuumE, W. L., Monoclonal antibodies against three major glycoproteins of varicella-zoster virus, Infect. Immun. 40: 381–388 (1983).PubMedGoogle Scholar
  85. 77.
    Guess, H. A., Broughton, D. D., Melton, L. J., and Kurland, L. T., Chickenpox hospitalizations among residents of Olmsted County, Minnesota, 1962 through 1981. A population based study, Am. J. Dis. Child. 138: 1055–1057 (1984).PubMedGoogle Scholar
  86. 78.
    Guess, H. A., Broughton, D. D., Melton, L. J., and Kurland, L. T., Epidemiology of herpes zoster in children and 94. adolescents: A population based study, Pediatrics 76: 512–517 (1985).PubMedGoogle Scholar
  87. 79.
    Gulick, R. M., Heathchiozzi, M., and Crumpacker, C. S., Varicella-zoster virus disease in patients with human immuno- deficiency virus infection, Arch. Derm. 126: 1086–1088 (1990).PubMedCrossRefGoogle Scholar
  88. 80.
    Gustafson, T. L., Lavely, G. B., Brawner, E. R., Hutcheson, R. H., Wright, P. F., and Schaffner, W., An outbreak of airborne nosocomial varicella, Pediatrics 70: 550–556 (1982).PubMedGoogle Scholar
  89. 81.
    Haake, D. A., Zakowski, P. C. Haake, D. L., and Bryson, Y. J., Early treatment with acyclovir for varicella pneumonia in otherwise healthy adults: Retrospective controlled study and review, Rev. Infect. Dis. 12: 788–798 (1990).PubMedCrossRefGoogle Scholar
  90. 82.
    Hacham, M., Leventon-Kriss, S., and Sarov, I., Enzymelinked immunosorbent assay for detection of virus-specific IgM antibodies to varicella-zoster virus, Intervirology 13: 214–222 (1980).PubMedCrossRefGoogle Scholar
  91. 83.
    Haggerty, R. J., and Eley, R. C., Varicella and cortisone, Pediatrics 18: 160–162 (1956).PubMedGoogle Scholar
  92. 84.
    Haikin, H., Leventonkriss, S., and Sarov, I., Antibody to varicella-zoster virus-induced membrane antigen; immunoperoxidase assay with air-dried target cells, J. Infect. Dis. 140: 601–604 (1979).PubMedCrossRefGoogle Scholar
  93. 85.
    Hayward, A., Levin, M., Wolf, W., Angelova, G., and Gilden, D., Varicella-zoster virus specific immunity after herpes zoster, J. Infect. Dis. 163: 873–875 (1991).PubMedCrossRefGoogle Scholar
  94. 86.
    Hellinger, W. C., Bolling, J. P., Smith, T. F., and Campbell, R. J., Varicella-zoster virus retinitis in a patient with Aids-related complex; case report and brief review of the acute retinal necrosis syndrome, Clinical Infect. Dis. 16: 208–212 (1993).CrossRefGoogle Scholar
  95. 87.
    Higa, K., Dan, K., and Manabe, H., Varicella-zoster virus infections during pregnancy: Hypothesis concerning the mechanisms of congenital malformations, Obstet. Gynecol. 69: 214–222 (1987).PubMedGoogle Scholar
  96. 88.
    Hondo, R., Yogo, Y., Kurata, T., And Aoyama, Y., Genome variation among varicella-zoster isolates derived from different individuals and from the same individuals, Arch. Virol. 93: 1–12 (1987).PubMedCrossRefGoogle Scholar
  97. 89.
    Hook, E. B., Orandi, M., Ten Bensel, R. W., Schamber, W. F., and ST. Geme, J. W., J., Familial fatal varicella, J.A.M.A. 206: 305–311 (1968).Google Scholar
  98. 90.
    Hope-Simpson, R. E., Infectiousness of communicable diseases in the household (measles, chickenpox, and mumps), Lancet 2: 549–554 (1952).CrossRefGoogle Scholar
  99. 91.
    Hopesimpson, R. E., The nature of herpes zoster; a long-term study and a new hypothesis, Proc. R. Soc. Med. 58: 9–20 (1965).Google Scholar
  100. 91a.
    Connor, J. D., Bryson, Y. J., and Balfour, H. H., Effect of oral acyclovir on pain resolution in herpes zoster: A reanalysis, J. Med. Virol. Suppl. 1: 93–96 (1993).Google Scholar
  101. 91b.
    Huse, D. M., Meissner, H. C., Lacey, M. J., and Oster, G., Childhood vaccination against chickenpox: An analysis of benefits and costs, J. Pediatr. 124: 869–874 (1994).PubMedCrossRefGoogle Scholar
  102. 92.
    Hyman, R. W., Ecker, J. R., and Tenser, R. B., Varicellazoster virus Rna in human trigeminal ganglia, Lancet 2: 814–816 (1983).PubMedCrossRefGoogle Scholar
  103. 93.
    Institute OF Medicine Committee ON Issues And Priorities For New Vaccine Development, Diseases of Importance in the United States, Appendix J: Prospects for immunizing against Herpesvirus varicellae, pp. 313–341, National Academy of Sciences, Washington, DC, 1985.Google Scholar
  104. 94.
    Jacobson, M. A., Berger, T. O., Fikrig, S., Becherer, P., Moohr, J. W., Stanat, S. C., and Biron, K. K., Acyclovirresistant varicella zoster virus after chronic oral acyclovir therapy in patients with acquired immunodeficiency syndrome (Aids), Ann. Intern. Med. 112: 1187–1191 (1990).CrossRefGoogle Scholar
  105. 95.
    Jordan, G. W., and Merigan, T. C., Cell-mediated immunity to varicella-zoster virus: In vitro lymphocyte responses, J. Infect. Dis. 130: 495–501 (1974).PubMedCrossRefGoogle Scholar
  106. 96.
    Josephson, A., and Gombert, M. E., Airborne transmission of nosocomial varicella from localized zoster, J. Infect. Dis. 158: 238–241 (1988).PubMedCrossRefGoogle Scholar
  107. 97.
    Jueljensen, B. E., A new look at infectious diseases: Herpes simplex and zoster, Br. Med. J. 1: 406–410 (1973).CrossRefGoogle Scholar
  108. 98.
    Kallander, C. F. R., Gronowitz, J. S., and Oldingstenkvist, E., Rapid diagnosis of varicella-zoster virus infection by detection of viral deoxythymidine kinase in serum and vesicle fluid, J. Clin. Microbiol. 17: 280–287 (1983).PubMedGoogle Scholar
  109. 99.
    Kapsenberg, J. G., Possible antigenic relationships between varicella-zoster virus and herpes simplex virus, Arch. Ges. Virusforsch. 15: 67–73 (1964).PubMedCrossRefGoogle Scholar
  110. 99a.
    KAss, E. M., Szaniawski, W. K., Levy, H., Leach, J., Srinivasan, K., and Rives, C., Rickettsialpox in a New York city hospital, 1980 to 1989, N. Engl. J. Med. 331: 1612–1617 (1994).PubMedCrossRefGoogle Scholar
  111. 100.
    Kidd, S., OzAki, T., Asada, H., Higashi, K., Kondo, K., Hayakawa, Y., Morishima, T., Takahashi, M., and Yamanishi, K., Detection of varicella-zoster virus (Vzv) Dna in clinical samples from patients with Vzv by the polymerase chain reaction, J. Clin. Microbiol. 29: 76–79 (1991).Google Scholar
  112. 101.
    Kjersem, H., and Jepsen, S., Varicella among immigrants from the tropics, a health problem, Scand. J. Soc. Med. 18: 171–174 (1990).PubMedGoogle Scholar
  113. 102.
    Koranda, F. C., Dehmel, E. M., Kahn, G., and Penn, I., Cutaneous complications in immunosuppressed renal homograft recipients, J.A.M.A. 229: 419–424 (1974).PubMedCrossRefGoogle Scholar
  114. 103.
    Kundratciz, K., Experimentelle Ubertragung von Herpes Zoster auf den Menschen und die Beziehungen von Herpes zoster zu Varicellen, Monatsschr. Kinderheilkd. 29: 516–522 (1925).Google Scholar
  115. 104.
    Laforet, E. G., and Lynch, C. L., Multiple congenital defects following maternal varicella. Report of a case, N. Engl. J. Med. 236: 534–537 (1947).PubMedCrossRefGoogle Scholar
  116. 105.
    Landry, M. L., And Hsiung, G. D., Diagnosis of dual herpes virus infection: Varicella and herpes simplex viruses, in: The Human Herpesviruses (A. J. Nahmias, W. R. Dowdle, and R. E Schinazi, Eds.), pp. 652–653, Elsevier, New York, 1981.Google Scholar
  117. 106.
    Larkin, M., Heckels, J. E., and Ogilvie, M. M., Antibody response to varicella-zoster virus surface glycoproteins in chickenpox and shingles, J. Gen. Virol. 66: 1785–1793 (1985).PubMedCrossRefGoogle Scholar
  118. 107.
    Leclair, J. M., Zaia, J. A., Levin, M. J., Congdon, R. G., and Goldmann, D. A., Airborne transmission of chickenpox in a hospital, N. Engl. J. Med. 302: 450–453 (1980).PubMedCrossRefGoogle Scholar
  119. 108.
    Levin, M. J., Murray, M., Rotbart, H. A., Zerbe, G. O., White, C. J., and Hayward, A. R., Immune response of elderly individuals to live attenuated varicella vaccine, J. Infect. Dis. 166: 253–259 (1992).PubMedCrossRefGoogle Scholar
  120. 109.
    Levin, M. J., Leventhal, S., and Masters, H. A., Factors influencing quantitative isolation of varicella virus, J. Clin. Microbiol. 19: 880–883 (1984).PubMedGoogle Scholar
  121. 109a.
    Levin, M. J., Murray, M., Zerbe, G. O., White, C. J., and Hayward, A. R., Immune responses of elderly persons 4 years after receiving a live attenuated varicella vaccine, J. Infect. Dis. 170: 522–526 (1994).PubMedCrossRefGoogle Scholar
  122. 109b.
    Lieu, T. A., Cochi, S. L., Halloran, M. E., Shinefield, H. R., Holmes, S. J., Wharton, M., and Washington, A. E., Costeffectiveness of a routine varicella vaccination program for US children, J.A.M.A. 271: 375–381 (1994).PubMedCrossRefGoogle Scholar
  123. 110.
    Lipscxirrz, B., Untersuchungen uber die Atiologie der Krankheiten des Herpesgruppe (Herpes zoster, Herpes genitalis, Herpes febrilis), Arch. Dermatol. Syph. Orig. 136: 428–482 (1921).Google Scholar
  124. 111.
    Lipton, S. V., and Brunell, P. A., Management of varicella exposure in a neonatal intensive care unit, J.A.M.A. 261: 17821784 (1989).Google Scholar
  125. 112.
    Locksley, R. M., Flournoy, N., Sullivan, K. M., and Meyers, J. D., Infection with varicella-zoster virus after marrow transplantation, J. Infect. Dis. 152: 1172–1181 (1985).PubMedCrossRefGoogle Scholar
  126. 112a.
    Lokke Jensen, B., Weismann, K., Mathiesen, L., and Klem Thomsen, H., Atypical varicella-zoster infection in Aids, Acta Denn. Venereol. (Stockh.) 73: 123–125 (1993).Google Scholar
  127. 113.
    London, W. P., and Yorke, J. A., Recurrent outbreaks of measles, chickenpox, and mumps. I. Seasonal variations in contact rates, Am. J. Epidemiol. 98: 453–468 (1972).Google Scholar
  128. 114.
    Longfield, J. N., Winn, R. E., Gibson, R. L., Juchau, S. V., and Hoffman, P. V., Varicella outbreaks in army recruits from Puerto Rico. Varicella susceptibility in a population from the tropics, Arch. Intern. Med. 150: 970–973 (1990).PubMedCrossRefGoogle Scholar
  129. 115.
    Lonnqvist, B., Ljungman, P., Bolme, P., Gahrton, G., Ringden, O., and Wahren, B., Frequency of reactivation of varicella-zoster virus (Vzv) infection with and without symptoms after bone marrow transplantation, Exp. Hematol. 13 (Suppl. 17): 72 (1985).Google Scholar
  130. 116.
    Luby, J. P., Ramirez-Ronda, C., Rinner, S., Hull, A., and Vergnemarini, P., A longitudinal study of varicella-zoster virus infections in renal transplant recipients, J. Infect. Dis. 135: 659–663 (1970).Google Scholar
  131. 117.
    Lux, S. E., Johnston, R. B., August, C. S., Say, B., Penchaszadeh, V. B., Rosen, E S., And Mckusick, V. A., Chronic neutropenia and abnormal cellular immunity in cartilage-hair hypoplasia, N. Engl. J. Med. 282: 231–236 (1970).PubMedCrossRefGoogle Scholar
  132. 117a.
    Lyall, E. G. H., Ogilvie, M. M., Smith, N. M., and Burns, S., Acyclovir-resistant varicella zoster and Hiv infection, Arch. Dis. Child. 70: 133–135 (1994).PubMedCrossRefGoogle Scholar
  133. 118.
    Lynfield, R., Herrin, J. T., and Rubin, R. H., Varicella in pediatric renal transplant recipients, Pediatrics 90: 216–220 (1992).PubMedGoogle Scholar
  134. 119.
    Mahalingam, R., Wellish, M. C., Dueland, A. N., Cohrs, R. J., and Gilden, D. H., Localization of herpes simplex virus and varicella zoster virus Dna in human ganglia, Ann. Neurol. 31: 444–448 (1992).PubMedCrossRefGoogle Scholar
  135. 120.
    Manson, M. M., Logan, W. P. D., and Loy, R. M., Rubella and Other Virus Infections during Pregnancy, Report 101, pp. 1–101, Ministry of Health, Her Majesty’s Stationery Office, London, 1960.Google Scholar
  136. 121.
    Maretic, A., And Cooray, M. P. M., Comparisons between chickenpox in a tropical and a European country, J. Trop. Med. Hyg. 66: 311–315 (1963).PubMedGoogle Scholar
  137. 122.
    Martin, J. H., Dohner, D. E., Wellinghoff, W. J., and Gelb, L. D., Restriction endonuclease analysis of Varicella-zoster vaccine virus and wild-type Dnas, J. Med. Virol. 9: 69–76 (1982).PubMedCrossRefGoogle Scholar
  138. 122a.
    Martin, K. A., Junker, A. K., Thomas, E. E., Allen, M. I., and Friedman, J. M., Occurrence of chickenpox during pregnancy in women seropositive for varicella-zoster virus, J. Infect. Dis. 170: 991–995 (1994).PubMedCrossRefGoogle Scholar
  139. 122b.
    Marwick, C., Lengthy tale of varicella vaccine development finally nears a clinically useful conclusion, J.A.M.A. 273: 833–836 (1995).PubMedCrossRefGoogle Scholar
  140. 123.
    Mcgregor, R. M., Herpes zoster, chickenpox and cancer in general practice, Br. Med. J. 1: 84–87 (1957).PubMedCrossRefGoogle Scholar
  141. 124.
    Mcgregor, R. S., Zitelli, B J, Urbach, A. H., Malatack, J. J., and Gartner, J. C., Varicella in pediatric orthotopic liver transplant recipients, Pediatrics 83: 256–261 (1989).PubMedGoogle Scholar
  142. 125.
    McKusicK, V. A., Fatal varicella (letter to the editor), J.A.M.A. 207: 370 (1969).CrossRefGoogle Scholar
  143. 126.
    Meier, J. L., Holman, R. E, Croen, K. D., Smialek, J. E., and Straus, S. E., Varicella-zoster virus transcription in human trigeminal ganglia, Virology 193: 193–200 (1993).PubMedCrossRefGoogle Scholar
  144. 127.
    Meszner, Z., Nyerges, G., And Bell, A. R., Oral acyclovir to prevent dissemination of varicella in immunocompromised children, J. Infection 26: 9–15 (1993).CrossRefGoogle Scholar
  145. 128.
    Meurisse, V., Miller, E., and Kensit, J., Varicella in maternity units, Lancet 1: 1100–1101 (1990).CrossRefGoogle Scholar
  146. 129.
    Meyers, J. D., Congenital varicella in term infants; risk reconsidered, J. Infect. Dis. 129: 215–217 (1974).PubMedCrossRefGoogle Scholar
  147. 130.
    Miller, A. E., Selective decline in cellular immune response to varicella-zoster in the elderly, Neurology (Minneap.) 30: 582–587 (1980).CrossRefGoogle Scholar
  148. 131.
    Miller, E., Vurdien, J., and Farrington, P., Shift in age in chickenpox, Lancet 1: 308–309 (1993).CrossRefGoogle Scholar
  149. 131a.
    Nader, S., Bergen, R., Shari, M., and Arvin, A. M., Age-related differences in cell-mediated immunity to varicella-zoster virus among children and adults immunized with live attenuated varicella vaccine, J. Infect. Dis. 171: 13–17 (1995).PubMedCrossRefGoogle Scholar
  150. 132.
    Nahass, G. T., Goldstein, B. A., Zhu, W. Y., Serfling, U., Penneys, N. S., and Leonardi, C. L., Comparison of Tzanck smear, viral culture, and Dna diagnostic methods in detection of herpes simplex and varicella-zoster infection, J.A.M.A. 268: 2541–2544 (1992).PubMedCrossRefGoogle Scholar
  151. 133.
    Naraqui, S., Jackson, G. G., Jonasson, O., and Yamashiroya, H. M., Prospective study of prevalence, incidence, and source of herpes virus infections in patients with renal allografts, J. Infect. Dis. 136: 531–540 (1977).CrossRefGoogle Scholar
  152. 133a.
    Nguyen, P., Reynaud, J., Pouzol, P, Munzer, M., Richard, O., and Francis, P., Varicella and thrombotic complications associated with transient protein C and protein S deficiencies in children, Eur. J. Pediatr. 153: 646–649 (1994).PubMedCrossRefGoogle Scholar
  153. 134.
    Nyerges, G., MEszNer, Z. Gyarmati, E., and Kerpelfronius, S., Acyclovir prevents dissemination of varicella in immunocompromised children, J. Infect. Dis. 157: 309–311 (1988).PubMedCrossRefGoogle Scholar
  154. 135.
    Oberg, G., and Svedmyr, A., Varicelliform eruptions in herpes zoster; some clinical and serological observations, Scand. J. Infect. Dis. 1: 47–49 (1969).PubMedGoogle Scholar
  155. 136.
    Osler, W., The Principles and Practice of Medicine, p. 65, Appleton, New York, 1892.Google Scholar
  156. 137.
    Ozaki, T., Ichikawa, T., Matsui, Y., Nagai, T., Asano, Y., Yaminishi, K., And Takahashi, M., Viremic phase in nonimmunocompromised children with varicella, J. Pediatr. 104: 85–87 (1984).PubMedCrossRefGoogle Scholar
  157. 138.
    Ozaki, T., Matsui, Y., Asano, Y., Okuno, T., Yamanishi, K., and Takahashi, M., Study of virus isolation from pharyngeal swabs in children with varicella, Am. J. Dis. Child. 143: 1448–1450 (1989).PubMedGoogle Scholar
  158. 139.
    Ozaki, T., Miwata, H., Matsui, Y., Kid, S., and Yamanishi, K., Varicella-zoster virus Dna in throat swabs, Arch. Dis. Child. 66: 333–334 (1991).PubMedCrossRefGoogle Scholar
  159. 140.
    Pahwa, S., Biron, K., Lim, W., Swenson, R, Kaplan, M. H., Sadick, N., and Pahwa, R., Continuous varicella-zoster infection associated with acyclovir resistance in a child with Aids, J.A.M.A. 260: 2879–2882 (1988).PubMedCrossRefGoogle Scholar
  160. 141.
    Pallett, A., and Nicholls, M. W. N., Varicella-zoster. Reactivation or reinfection?, Lancet 1: 160 (1986).PubMedCrossRefGoogle Scholar
  161. 142.
    Paryani, S. G., and Arvin, A. M., Intrauterine infection with varicella-zoster virus after maternal varicella, N. Engl. J. Med 314: 1542–1546 (1986).PubMedCrossRefGoogle Scholar
  162. 143.
    Paryani, S. G., Arvin, A. M., Koropchak, C. M., Wrl l’EK, A. E., Amylon, M. D., Dobkin, M. B., And Budinger, M. D., Comparison of varicella-zoster antibody titers in patients given intravenous immune serum globulin or varicella-zoster immune globulin, J. Pediatr. 105: 200–205 (1984).PubMedCrossRefGoogle Scholar
  163. 143a.
    Pastuszak, A. L., Levy, M., Schick, B., Zuber, C., Feldcamp, M., Gladstone, J., Barlevy, F., Jackson, E., Donnenfeld, A., Meshing, W., and Karen, G., Outcome after maternal varicella in the first 20 weeks of pregnancy, N. Engl. J. Med. 330: 901–905 (1994).PubMedCrossRefGoogle Scholar
  164. 144.
    Perronne, C., Lazanas, M., Leport, C., Simon, F., Salmon, D., Dallot, A., and Vilde, J.-L., Varicella in patients infected with the human immunodeficiency virus, Arch. Dernurtol. 126: 1033–1036 (1990).CrossRefGoogle Scholar
  165. 145.
    Pons, J.-C., Rozenberg, E, Imbert, M.-C., Lebron, P., Olivennes, R, Lelaidier, C., Straub, N., Vial, M.; and Frydman, R., Prenatal diagnosis of second-trimester congenital varicella syndrome, Prenat. Diagn. 12: 975–976 (1992).PubMedCrossRefGoogle Scholar
  166. 146.
    Preblud, S. R., Age-specific risks of varicella complications, Pediatrics 68: 14–17 (1981).PubMedGoogle Scholar
  167. 147.
    Preblud, S. R., Cochi, S. L., and Orenstein, W. A., Letter to the editor, N. Engl. J. Med. 315: 1416–1417 (1986).Google Scholar
  168. 148.
    Preblud, S. R., and Dangelo, L. J., Chickenpox in the United States, 1972–1977, J. Infect. Dis. 140: 257–260 (1979).PubMedCrossRefGoogle Scholar
  169. 149.
    Ragozzino, M. W., Melton, L. J., Iii, Kurland, L. T., Chu, C. P., and Perry, H. O., Population-based study of herpes zoster and its sequelae, Medicine 61: 310–316 (1982).PubMedCrossRefGoogle Scholar
  170. 150.
    Rasmussen, L., Holmes, A. R., Hofmeister, R., and Merigan, T., Multiplicity-dependent replication of varicella-zoster virus in interferon treated cells, J. Gen. V irol. 35: 361–368 (1977).Google Scholar
  171. 151.
    Rifkind, D., The activation of varicella-zoster virus infections by immunosuppressive therapy, J. Lab. Clin. Med. 68: 463–474 (1966).PubMedGoogle Scholar
  172. 152.
    Roberts, G. B., Fyfe, J. A., Gaillard, R. K., and Short, S. A., Mutant varicella-zoster thymidine kinase; correlation of clinical resistance and enzyme impairment, J. V irol. 65: 6407–6413 (1991).Google Scholar
  173. 153.
    Ross, A. H., Modification of chickenpox in family contacts by administration of gamma globulin, N. Engl. J. Med 267: 369–376 (1962).PubMedCrossRefGoogle Scholar
  174. 154.
    Ross, C. A. C., Subak Sharpe, J. H., And Ferry, E, Antigenic relationship of varicella-zoster and herpes simplex, Lancet 2: 708–711 (1965).PubMedCrossRefGoogle Scholar
  175. 155.
    Ruckdeschel, J. C., Schimpff, S. C., Smyth, A. C., and Mardiney, M. R., Herpes zoster and impaired cell-associated immunity to the varicella-zoster virus in patients with Hodgkin’s disease, Am. J. Med. 62: 77–85 (1977).PubMedCrossRefGoogle Scholar
  176. 156.
    Sabin, A. B., Neurotropic virus diseases of man, J. Pediatr. 19: 445–451 (1941).CrossRefGoogle Scholar
  177. 157.
    Salomon, J. B., Gordon, J. E., And Scrimshaw, N. S., Studies of diarrheal disease in Central America. X. Associated chickenpox, diarrhea and kwashiorkor in a highland Guatemalan village, Am. J. Trop. Med. 15: 997–1002 (1966).Google Scholar
  178. 158.
    Schaap, G. J. P., And Huisman, J., Simultaneous rise in complement fixing antibodies against herpesvirus hominis and varicellazoster virus, Arch. Ges. Virusforsch. 17: 495–503 (1968).Google Scholar
  179. 158a.
    Schmader, K., George, L. K., Burchett, B. M., Pieper, C. F., and Hamilton, J. D., Racial differences in the occurence of zoster, J. Infect. Dis. 171: 701–704 (1995).PubMedCrossRefGoogle Scholar
  180. 159.
    Schmidt, N. J., Lennette, E. H., and Magoffin, R. L., Immunologic relationship between herpes simplex and varicella-zoster viruses demonstrated by complement-fixation, neutralization, and fluorescent antibody tests, J. Gen. V irol. 4: 321–328 (1969).Google Scholar
  181. 160.
    School Epidemics Committee OF Great Britain, Epidemics in Schools, Medical Research Council, Special Report Series No. 227, London, His Majesty’s Stationery Office, 1938.Google Scholar
  182. 161.
    Selby, P. J., Powles, R. L., Jameson, B., Kay, H. E. M., Watson, J. G., Thornton, R., Morgenstern, G., Clink, H. M., McElwain, T. J., Prentice, H. G., Corrigham, R., Ross, M. G., Hoffbrand, A. V., and Brigden, D., Parenteral acyclovir therapy for herpesvirus infection in man, Lancet 2: 1267–1270 (1979).PubMedCrossRefGoogle Scholar
  183. 162.
    Shanley, J., Myers, M., Edmond, B., and Steele, R, Enzyme-linked immunosorbent assay for detection of antibody to varicella-zoster virus, J. Clin. Microbiol. 15: 208–211 (1982).PubMedGoogle Scholar
  184. 163.
    Shehab, Z., and Brunell, P. A., Enzyme-linked immunosorbent assay for susceptibility to varicella, J. Infect. Dis. 148: 472476 (1983).Google Scholar
  185. 164.
    Siegel, M., Congenital malformations following chickenpox, measles, mumps, and hepatitis: Results of a cohort study, J.A.M.A. 226: 1521–1524 (1973).PubMedCrossRefGoogle Scholar
  186. 165.
    Siegel, M., and Fuerst, H. T., Low birth weight and maternal virus disease: A prospective study of rubella, measles, mumps, chickenpox, and hepatitis, J.A.M.A. 197: 680–684 (1966).PubMedCrossRefGoogle Scholar
  187. 166.
    Sinha, D. P., Chickenpox-a disease predominantly affecting adults in West Bengal, India, Int. J. Epidemiol. 5: 367–374 (1976).PubMedCrossRefGoogle Scholar
  188. 167.
    Smith, G. R., Mckenzie, J. M., Marmer, D. J., and Steele, R W., Psychologic modulation of the human immune response to varicella zoster, Arch. Intern. Med. 145: 2110–2112 (1985).PubMedCrossRefGoogle Scholar
  189. 168.
    Soriano, V., Bru, F., and Gonzalezlahos, J., Fatal varicella hepatitis in a patient with Aids, J. Infect. 25: 107 (1992).PubMedCrossRefGoogle Scholar
  190. 169.
    Steiner, Zur Inokulation der Varicellen., Wien. Med. Wochenschr. 25: 306 (1875).Google Scholar
  191. 170.
    Stevens, D. A., Ferrington, R. A., Jordan, G. W., and Merigan, T. C., Cellular events in zoster vesicles; relation to clinical course and immune parameters, J. Infect. Dis. 131: 509–515 (1975).PubMedCrossRefGoogle Scholar
  192. 171.
    SToKEs, J., JR., Chickenpox, in: Preventive Medicine in World War II, Vol. IV, Communicable Diseases, Transmitted Chiefly Through Respiratory and Alimentary Tracts, (E. C. Hoff and R. M. Hoff, Eds.), pp. 55–56, Department of Army, Washington, DC, 1958.Google Scholar
  193. 172.
    Straus, S. E., Shingles; sorrows, salves, solutions, J.A.M.A. 269: 1836–1839 (1993).PubMedCrossRefGoogle Scholar
  194. 172a.
    Straus, S. E., Overview: The biology of varicella-zoster virus infection, Ann. Neurol. Suppl. 35: 4–8 (1994).CrossRefGoogle Scholar
  195. 173.
    Straus, S. E., Hay, J., Smith, H., and Owens, J., Genome differences among varicella-zoster virus isolates, J. Gen. V irol. 64: 1031–1041 (1983).Google Scholar
  196. 174.
    Straus, S. E., Reinhold, W., Smith, H. A., Ruyechan, W. T., Henderson, D. K., Blaese, R. M., and Hay, J., Endonuclease analysis of viral Dna from varicella and subsequent zoster infections in the same patient, N. Engl. J. Med. 311: 1362–1364 (1984).PubMedCrossRefGoogle Scholar
  197. 175.
    Strom, J., Social development and declining incidence of some common epidemic diseases in children; a study of the incidence in different age groups in Stockholm, Acta Paediatr. Scand. 56: 159–163 (1967).PubMedCrossRefGoogle Scholar
  198. 176.
    Takahashi, M., Current status and prospects of live varicella vaccine, Vaccine 10: 1007–1014 (1992).PubMedCrossRefGoogle Scholar
  199. 177.
    Takahashi, M., Okuno, Y., Otsuka, T., Osame, J., Takamizawa, A., Sasudo, T., and Kuso, T., Development of a live attenuated varicella vaccine, Biken J. 18: 25–33 (1975).PubMedGoogle Scholar
  200. 178.
    Takahashi, M., Otsuka, T., Okuno, Y., Asano, Y., Yazaki, T., and Isomura, S., Live vaccine used to prevent the spread of varicella in children in hospital, Lancet 2: 1288–1290 (1974).PubMedCrossRefGoogle Scholar
  201. 179.
    Talbot, G. H., Skros, M., Fisher, M., and Friedman, H., Immunologic evidence of reinfection with varicella-zoster virus, J. Infect. Dis. 149: 1035–1036 (1984).PubMedCrossRefGoogle Scholar
  202. 179a.
    Terada, K., Kawano, S., Yoshihiro, A., Miyashima, H., and Morita, T., Characteristics of herpes zoster in otherwise normal children, Pediatr. Infect. Dis. J. 12: 960–961 (1993).PubMedCrossRefGoogle Scholar
  203. 180.
    Tyzzer, E. E., The histology of the skin lesions in varicella, Philipp. J. Sci. 1: 349–372 (1906).Google Scholar
  204. 181.
    Uduman, S. A., Gershon, A. A., and Brunell, P. A., Rapid diagnosis of varicella-zoster by agar-gel diffusion, J. Infect. Dis. 126: 193–195 (1972).PubMedCrossRefGoogle Scholar
  205. 182.
    Verroust, E, Lemay, D., and Laurian, Y., High frequency of herpes zoster in young hemophiliacs, N. Engl. J. Med. 316: 166–167 (1987).PubMedCrossRefGoogle Scholar
  206. 183.
    Virolainen, M., Savilahiti, E., Katila, I., and Perhentupa, J., Cellular and humoral immunity in cartilage-cell hypoplasia, Pediatr. Res. 12: 961–966 (1978).PubMedCrossRefGoogle Scholar
  207. 184.
    Von Bokay, J., Uber den aetiologischen Zussammenhang der Varicellen mit gewissen Fallen von Herpes zoster, Wien. Klin. Wochenschr. 22: 1323–1326 (1909).Google Scholar
  208. 185.
    Wade, N. A., Lepow, M. L., Veazey, J., and Meuwissen, H. J., Progressive varicella in three patients with Wiskott-Aldrich syndrome; treatment with adenine anabinoside, Pediatrics 75: 672–675 (1985).PubMedGoogle Scholar
  209. 186.
    Wallace, M. R., Bowler, W. A., Murray, N. B., Brodine, S. K., and Oldfield, E. C., Iii, Treatment of adult varicella with oral acyclovir. A randomized, placebo-controlled trial, Ann. Intern. Med. 117: 358–363 (1992).PubMedCrossRefGoogle Scholar
  210. 187.
    Waner, J. L., and Weller, T. H., Varicella-zoster virus, in: Diagnostic Procedures for Viral, Rickettsial, and Chlamydial Infections, 6th ed. (N. J. Schmidt And R. W. Emmons, Eds.), pp. 379–406, American Public Health Association, Washington, DC, 1979.Google Scholar
  211. 187a.
    Watson, B., Boardman, C., Laufer, S., Piercy, S., Tustin, N., Olaleye, D., Cnaan, A., and Starr, S. E., Humoral and cell-mediated immune responses in healthy children after one or two doses of varicella vaccine, Clin. Infect. Dis. 20: 316–319 (1995).CrossRefGoogle Scholar
  212. 188.
    Weber, D. M., and Pellecchia, J. A., Varicella pneumonia; study of prevalence in adult men, J.A.M.A. 192: 572–573 (1965).PubMedCrossRefGoogle Scholar
  213. 189.
    Weber, D. J., Rutala, W. A., and Parham, C., Impact and costs of varicella prevention in a university hospital, Am. J. Public Health 78: 19–23 (1988).PubMedCrossRefGoogle Scholar
  214. 190.
    Weigle, K. A., and Grose, C., Molecular dissection of the humoral immune response to individual varicella-zoster viral proteins during chickenpox, quiescence, reinfection, and reactivation, J. Infect. Dis. 149: 741–749 (1948).CrossRefGoogle Scholar
  215. 191.
    Weller, T. H., The propagation in vitro of agents producing inclusion bodies derived from varicella and herpes zoster, Proc. Soc. Exp. Biol. Med. 83: 340–346 (1953).PubMedCrossRefGoogle Scholar
  216. 192.
    Weller, T. H., Varicella and herpes zoster; a perspective and overview, J. Infect. Dis. 166 (Suppl. 1): S1–6 (1992).PubMedCrossRefGoogle Scholar
  217. 193.
    Weller, T H, Varicella and herpes zoster. Changing concepts of the natural history, control, and importance of a not so benign virus, N. Engl. J. Med. 309: 1362–1368 (1983).PubMedCrossRefGoogle Scholar
  218. 194.
    Weller, T. H., and Coons, A. H., Fluorescent antibody studies with agents of varicella and herpes zoster propagated in vitro, Proc. Soc. Exp. Biol. Med. 86: 789–794 (1954).PubMedCrossRefGoogle Scholar
  219. 195.
    Weller, T. H., and Stoddard, M. B., Intranuclear inclusion bodies in cultures of human tissue inoculated with varicella vesicle fluid, J. Immunol. 68: 311–319 (1952).PubMedGoogle Scholar
  220. 196.
    Weller, T. H., and Witton, H. M., The etiologic agents of varicella and herpes zoster; serologic studies with the viruses as propagated in vitro, J. Exp. Med. 108: 869–890 (1958).PubMedCrossRefGoogle Scholar
  221. 197.
    Weller, T. H., Witon, H. M., and Bell, E. J., The etiologic agents of varicella and herpes zoster; isolation, propagation, and cultural characteristics in vitro, J. Exp. Med. 108: 843–868 (1958).PubMedCrossRefGoogle Scholar
  222. 198.
    Wells, M. W., and Holla, W. A., Ventilation in the flow of measles and chickenpox through a community, J.A.M.A. 142: 1337–1344 (1950).CrossRefGoogle Scholar
  223. 199.
    White, E., Chickenpox in Kerala, India, Indian J. Public Health 22: 141–151 (1950).Google Scholar
  224. 200.
    White, R. J., Simmons, L., and Wilson, R. B., Chickenpox in young anthropoid apes; clinical and laboratory findings, J. Am. Vet. Med. Assoc. 161: 690–692 (1972).PubMedGoogle Scholar
  225. 201.
    W.H.O. Meeting, Diagnosis of human herpesviruses: Memorandum from a W.H.O. meeting, Bull. World Health Organ. 69: 277–283 (1991).Google Scholar
  226. 202.
    Whitley, R. J., and Gnann, J. W., Acyclovir: A decade later, N. Engl. J. Med 327: 782–789 (1992).PubMedCrossRefGoogle Scholar
  227. 203.
    Whitley, R. J., Gnann, J. W., Hinthorn, D., Liu, C., Pollard, R. B., Hayden, F., Mertz, G. J., Oxman, M., Soong, S.-J., and The Niaid Collaborative Antiviral Study Group, Disseminated herpes zoster in the immunocompromised host: A comparative trial of acyclovir and vidarabine, J. Infect. Dis. 165: 450–455 (1992).CrossRefGoogle Scholar
  228. 204.
    Williams, V., Gershon, A., and Brunell, P. A., Serologic response to varicella-zoster membrane antigens measured by indirect immunofluorescence, J. Infect. Dis. 130: 669–672 (1974).PubMedCrossRefGoogle Scholar
  229. 205.
    Wilson, A., Sharp, M., Koropchak, C. M., Ting, S. F., and Arvin, A. M., Subclinical varicella-zoster viremia, herpes zoster, and T lymphocyte immunity to varicella-zoster antigens after bone marrow transplantation, J. Infect. Dis. 165: 119–126 (1992).PubMedCrossRefGoogle Scholar
  230. 206.
    Wifson, D., Bressani, R., and Scrimshaw, N. S., Infection and nutritional status. I. Effect of chickenpox on nitrogen metabolism in children, Am. J. Clin. Nutr. 9: 154–158 (1961).Google Scholar
  231. 207.
    Winsnes, R., Efficacy of zoster immunoglobulin in prophylaxis of varicella in high-risk patients, Acta Paediatr. Scand. 67: 7782 (1978).CrossRefGoogle Scholar
  232. 208.
    WreghrTT, T. G., Tedder, R. S., Naginton, J., and Ferns, R. B., Antibody assays for varicella virus: Comparison of competitive enzyme-linked immunosorbent assay (Elisa), competitive radioimmunoassay (Ria), complement fixation, and indirect fluorescence assays, J. Med. Viral. 13: 361–370 (1984).CrossRefGoogle Scholar
  233. 209.
    Yorke, J. A., and London, W. P., Recurrent outbreaks of measles, chickenpox, and mumps. H. Systematic differences in contact rates and stochastic effects, Am. J. Epidemiol. 98: 469–482 (1973).PubMedGoogle Scholar
  234. 210.
    Zaia, J. A., Leary, P. L., and Levin, M. J., Specificity of the blastogenic response of human mononuclear cells to herpesvirus antigens, Infect. Immun. 20: 646–651 (1978).PubMedGoogle Scholar
  235. 211.
    Zaia, J. A., Levin, M. J., Preblud, S. R., Leszczynski, J., Wright, G. G., Ellis, R. J., Curtis, A. C., Valerio, M. A., and LE Gore, J., Evaluation of varicella-zoster immune globulin: Protection of immunosuppressed children after household exposure to varicella, J. Infect. Dis. 147: 737–743 (1983).PubMedCrossRefGoogle Scholar
  236. 212.
    Zaia, J. A., Levin, M. J., Wright, G. G., and Grady, G. F., A practical method for preparation of varicella-zoster immune globulin, J. Infect. Dis. 137: 601–604 (1978).PubMedCrossRefGoogle Scholar
  237. 213.
    Zaia, J. A., and Oxman, M. N., Antibody to varicella-zoster virus-induced membrane antigen: Immunofluorescence assay using monodisperse glutaraldehyde-fixed target cells, J. Infect. Dis. 136: 519–530 (1977).PubMedCrossRefGoogle Scholar
  238. 214.
    Ziegler, T., Detection of varicella-zoster viral antigens in clinical specimens by solid phase enzyme immunoassay, J. Infect. Dis. 150: 149–154 (1984).PubMedCrossRefGoogle Scholar
  239. 215.
    Zinsser, H., Immunology of infections by filterable virus agents, in: Virus and Rickettsial Diseases, pp. 89–117, Harvard University Press, Cambridge, 1940.Google Scholar

Suggested Reading

  1. Gordon, J. E., Chickenpox: An epidemiological review, Am. J. Med. Sci. 244: 362–389 (1962).PubMedCrossRefGoogle Scholar
  2. Gelb, L. D., Varicella-zoster virus, in: Virology, 2nd ed. (B N Fields and D. M. Knipe, Eds.), pp. 2011–2054, Raven Press, New York, 1990.Google Scholar

Copyright information

© Springer Science+Business Media New York 1997

Authors and Affiliations

  • Thomas H. Weller
    • 1
  1. 1.Department of Tropical Public HealthHarvard School of Public HealthBostonUSA

Personalised recommendations